Medication info
Anicra Tablet 625 mg (Amoxicillin Hydrate - Potassium Clavulanate (4:1))

Anicra Tablet 625 mg (Amoxicillin Hydrate - Potassium Clavulanate (4:1))

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
An Kuk Pharmaceutical Co., Ltd.
Appearance
This medication is a white or almost white oblong film-coated tablet.
Packaging
40 tablets/PTP
Approval status
Active

MFDS item code 201310382 · Approved 2013.11.29 · Insurance code 650204130

Summary

Main use
Treatment of respiratory infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when it is administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours, or 500mg/125mg of amoxicillin/potassium clavulanate per dose. 10 mL/min or less Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, or 500mg/125mg of amoxicillin/potassium clavulanate per dose. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis (because serum concentrations of both amoxicillin and clavulanate decrease).
Child dose
Children 12 years of age and older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
An Kuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchial pneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic inflammatory disease
View approved original text

This medication is used to treat various infectious diseases caused by a variety of bacteria. It is effective against respiratory infections including acute and chronic bronchitis, pneumonia, as well as tonsillitis, sinusitis, and otitis media. Additionally, it is used for urogenital infections such as cystitis, urethritis, and pyelonephritis, as well as gonorrhea and pelvic inflammatory disease. It helps improve skin and soft tissue infections such as boils, abscesses, and wound infections, and is also beneficial for the treatment of osteomyelitis and dental infections. It is effective against various resistant bacteria, making it widely and reliably used. Therefore, this medication is used to treat several bacterial infections.

How to take

Adult dose

The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when it is administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours, or 500mg/125mg of amoxicillin/potassium clavulanate per dose. 10 mL/min or less Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, or 500mg/125mg of amoxicillin/potassium clavulanate per dose. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis (because serum concentrations of both amoxicillin and clavulanate decrease).

Child dose

Children 12 years of age and older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. Children: Reduce the dose in the same manner.

Precautions

This medication should not be administered to patients with hypersensitivity to specific ingredients or beta-lactam antibiotics. Patients with viral infections such as infectious mononucleosis or lymphocytic leukemia are at increased risk of rash; caution is required. It is advisable not to use this medication in patients who have previously experienced liver dysfunction or jaundice due to this medication or penicillin-class drugs. In patients with impaired liver function, use with caution as the drug may worsen liver function. In patients with moderate to severe renal impairment, dosing intervals should be adjusted as drug concentrations may increase. Patients with allergic tendencies or family histories may have severe reactions to the medication and should be monitored closely. Patients who have difficulty with oral intake or poor nutritional status, especially the elderly, should take caution due to the risk of bleeding from vitamin K deficiency. Patients with gastrointestinal diseases with vomiting or diarrhea may not absorb the medication properly. This medication can cause gastrointestinal side effects such as diarrhea, gastroenteritis, and vomiting, and in severe cases, pseudomembranous colitis may occur, so consultation with a doctor should occur immediately if symptoms appear. Symptoms of liver dysfunction have been rarely reported, especially in the elderly and males, so liver function testing may be necessary. Skin rashes, hives, and severe allergic reactions may occur, and if these symptoms arise, medication should be discontinued and physician's instructions followed. Hematological side effects, such as leukopenia and anemia, have been rarely reported, necessitating regular blood tests. Central nervous system reactions, such as anxiety, drowsiness, and seizures, can occur rarely, so any unusual symptoms should be reported. Renal function may deteriorate, so renal function tests should be performed to monitor the condition. This medication may interact with other drugs, so if you are taking any other medications, you must inform your healthcare provider. Pregnant or nursing women should use this medication cautiously and it is particularly advised not to use during the first three months of pregnancy. Usage in children, particularly those under 12 years of age or weighing less than 40 kg, is not recommended. Elderly patients may experience abnormal reactions more frequently due to diminished physiological function, so dosage and administration intervals should be adjusted and monitored closely. In cases of overdose, gastrointestinal symptoms, renal failure, and seizures may occur, necessitating immediate contact with a healthcare provider. This medication should be stored in a dried place below 25 degrees Celsius, and the safe usage period does not exceed 14 days, depending on the indications.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, soft stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, blood in stool, itching, erythema multiforme, mucous membrane syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized exanthematous pustulosis, eosinophilia, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, burning, increased secretions, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, convulsions, antispasmodic, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B deficiency symptoms, linear IgA disease, dysgeusia, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, decreased urine output, renal failure, epileptic seizures, hypersensitivity shock, skin reactions, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is contained in a sealed container to protect it from moisture and air. When storing, it is advised to keep it in a cool place with a temperature between 1 and 25 degrees Celsius. This helps maintain the effectiveness of the medication and prevents deterioration.

Appearance and packaging

Appearance

This medication is a white or almost white oblong film-coated tablet.

Package unit

40 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.